DNCA is a neutral lipid used in lipid nanoparticles (LNPs) for siRNA and cyclic di-GMP delivery. It reduces tumor growth and improves immune response in melanoma and breast cancer mouse models without impacting animal weight. Reagent grade, for research purpose.
Usually ships within 24 hours.